60 Degrees Pharmaceuticals Warrant
SXTPW
5 hedge funds and large institutions have $12.2K invested in 60 Degrees Pharmaceuticals Warrant in 2026 Q2 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 3 closing their positions.
38% less funds holding
Funds holding: 8 → 5 (-3)
50% less capital invested
Capital invested by funds: $24.4K → $12.2K (-$12.2K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 3
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Mariner
Overland Park,
Kansas
|
-$2K |
| 2 |
TSS
Two Sigma Securities
New York
|
-$1.14K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$621 |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$342 |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$3 |
SXTPW Hedge Fund Activity: Q2 2026 in Review
5 of the 8,318 institutional investors tracked by Wall St. Rank reported a position in 60 Degrees Pharmaceuticals Warrant (SXTPW) for Q2 2026, worth a combined $12.2K — down 50% from $24.4K a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of SXTPW and 0 opened new positions — a net loss of 3 holders — while 2 trimmed existing stakes and 0 added.
The largest seller was Mariner, exiting entirely with an estimated $2K sold.
- 5 institutional investors held 60 Degrees Pharmaceuticals Warrant (SXTPW) as of Q2 2026, down from 8 in Q1 2026.
- Funds reported $12.2K of 60 Degrees Pharmaceuticals Warrant stock for Q2 2026, down 50% quarter-over-quarter.
- 0 funds opened new 60 Degrees Pharmaceuticals Warrant positions in Q2 2026 and 3 closed out, a net change of -3 holders.
- The largest 60 Degrees Pharmaceuticals Warrant seller in Q2 2026 was Mariner, an estimated $2K sold.
Based on aggregated 13F filings for Q2 2026.